Donald Trump hinted that he could have an “October surprise” in a SARS-CoV-2 vaccine. That isn’t going to happen. The closest is Pfizer’s announcement that it may apply for emergency authorization for its vaccine before the end of November. But, of course, that’s after the election.
The pharmaceutical companies, fortunately, are more interested in preserving their credibility than in currying Trump’s favor. Perhaps they have calculated that Trump is unlikely to win a second term.
ProPublica has a long article on how vaccines are approved. If you want the whole story, check it out. Here’s a tl;dr to provide more of a checklist.Read More
One of the many damages Donald Trump inflicts on the country is the inability to focus on events elsewhere in the world. Secretary of State Mike Pompeo uses Trump’s distractions to move closer to war with Iran.
Pompeo’s diplomacy begins by presenting a list of impossible demands to establish leverage for his next moves. In the case of arms control, the next move has been to pick up his marbles and go home. The US believes that Russia has been violating treaties. Instead of using the treaties’ mechanisms to bring Russia back into compliance, the US representative insisted that Russia publicly admit to its violations. When it didn’t, the US withdrew from the intermediate-range missile treaty and shot off a missile that would have violated the treaty. They are using the same strategy now to allow the New START Treaty, the last of the big arms control treaties, to lapse.Read More